Epstein File EFTA00605809: Warrant, Israel and Surveillance (DS9)

Epstein Index›Documents›EFTA00605809

💨IMPACT LEVEL 1 — MEH

Epstein File EFTA00605809: Warrant, Israel and Surveillance (DS9)

Financial RecordDate unavailableEFTA006058091 keyword hits

0

views

0

shares

0

reactions

0

persons

5

keywords

6

excerpts

This document describes an investment opportunity in Check Cap, an Israeli medical technology company founded in 2005 with headquarters in Carmel, Israel. The offering includes terms of $4-8 million USD with a 25% discount, 5% interest, and 100% warrant coverage for four years at 120% of offering price. The document includes information about the company's clinical surveillance programs and lists board members including Professor Nadir Arber from Tel Aviv Sourasky Medical Center and Steve Hanley, former president of Covidien's Imaging Solutions unit.

👤 Named in This Document

No named persons linked yet

🔑 Evidence Keywords

warrant Israel surveillance Tel Aviv insertion

📋 Key Excerpts6

PersonKeyword

Excerpt 1

Minimum: US$4m; Maximum: US$8m Terms highly attractive: Discount 25% Interest 5% **Warrant** coverage 100% * * Warrants for four years, at 120% of Offering

Excerpt 2

standard of colon 3D imagery Check Cap May 2014 Non Confidential EFTA00605809 Company Overview Founded - - 2005 Check Cap Corporate Headquarters - Carmel, **Israel**

Excerpt 3

consequently on survival rates from this disease" Professor Nadir Arber, Head of Integrated Cancer Prevention Center, Tel Aviv Sourasky Medical Center, **Israel**